Inhibition of TAK1 by RNAi knockdown of TAB1 significantly suppressed tumor growth and metastasis in vivo, suggesting that TAK1 is a potential therapeutic target for breast cancer. The gene discussed is TAB1; the disease is breast carcinoma.